Nuclear factor-κB/Rel proteins: A point of convergence of signalling pathways relevant in neuronal function and dysfunction

Biochemical Pharmacology

Volumn 57, Issue 1, 1999, Pages 1-7

  Grilli, Mariagrazia ^a   Memo, Maurizio ^b  

^a San Raffaele Science Park   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Alzheimer's disease; Anti inflammatory drugs; Apoptosis; Glutamate; Neurodegeneration; NF B Rel; Parkinson's disease; Transcriptional pharmacology

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CURCUMIN; CYCLOSPORIN A; CYTOKINE; DEFEROXAMINE; EPIGALLOCATECHIN; GLUCOCORTICOID; GLUTAMIC ACID; HERBIMYCIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; INTERLEUKIN 10; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PROTEIN TYROSINE KINASE INHIBITOR; SALICYLIC ACID DERIVATIVE; TEPOXALIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ONCOPROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN INFECTION; DRUG MECHANISM; HUMAN; HUMAN TISSUE; INFLAMMATION; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FAMILY; REVIEW; VIRUS INFECTION; ANIMAL; BRAIN; GENE EXPRESSION REGULATION; GENETICS; IMMUNITY; METABOLISM; NERVE CELL; NERVE DEGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY; INFLAMMATION; NERVE DEGENERATION; NEURONS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; TRANSCRIPTION FACTORS;

EID: 0032590061     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00214-7     Document Type: Article

References (60)

1. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:1986;705-716.
2. Grilli M., Chiu J.J.S., Lenardo M.J. NF-κB and Rel Participants in a multiform transcriptional regulatory system . Int Rev Cytol. 143:1993;1-62.
3. Baldwin A.S. The NF-κB and IκB proteins New discoveries and insights . Annu Rev Immunol. 14:1996;649-681.
4. O'Neill L.A.J., Kaltschmidt C. NF-κB A crucial transcription factor for glial and neuronal cell function . Trends Neurosci. 20:1997;252-258.
5. Schütze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., Krönke M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell. 71:1992;765-776.
6. Rattner A., Korner M., Walker M.D., Citri Y. NF-κB activates the HIV promoter in neurons. EMBO J. 12:1993;4261-4267.
7. Kaltschmidt C., Kaltschmidt B., Baeuerle P.A. Brain synapses contain inducible forms of the transcription factor NF-κB. Mech Dev. 43:1993;135-147.
8. Kaltschmidt C., Kaltschmidt B., Neumann H., Wekerle H., Baeuerle P.A. Constitutive NF-κB activity in neurons. Mol Cell Biol. 14:1994;3981-3992.
9. Grilli M., Ribola M., Alberici A., Valerio A., Memo M., Spano P.F. Identification and characterization of a κB/Rel binding site in the regulatory region of the amyloid precursor protein gene. J Biol Chem. 270:1995;26774-26777.
10. Guerrini L., Blasi F., Denis-Donini S. Synaptic activation of NF-κB by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci USA. 92:1995;9077-9081.
11. Kaltschmidt C., Kaltschmidt B., Baeuerle P.A. Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons. Proc Natl Acad Sci USA. 92:1995;9618-9622.
12. Meberg P.J., Kinney W.R., Valcourt E.G., Routtenberg A. Gene expression of the transcription factor NF-κB in hippocampus Regulation by synaptic activity . Brain Res Mol Brain Res. 38:1996;179-190.
13. Suzuki T., Mitake S., Okumura-Noji K., Yang J.-P., Fujii T., Okamoto T. Presence of NF-κB-like and IκB-like immunoreactivities in postsynaptic densities. Neuroreport. 8:1997;2931-2935.
14. Sparacio S.M., Zhang Y., Vilcek J., Benveniste E.N. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κB-like nuclear protein. J Neuroimmunol. 39:1992;231-242.
15. Kaltschmidt C., Kaltschmidt B., Lannes-Vieira J., Kreutzberg G.W., Wekerle H., Baeuerle P.A., Gehrmann J. Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis. J Neuroimmunol. 55:1994;99-106.
16. Carter B.D., Kaltschmidt C., Kaltschmidt B., Offenhäuser N., Böhm-Matthaei R., Baeuerle P.A., Barde Y.-A. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75. Science. 272:1996;542-545.
17. Hou Y.N., Vlaskovska M., Cebers G., Kasakov L., Liljiequist S., Terenius L. A μ-receptor opioid agonist induces AP-1 and NF-κB transcription factor activity in primary cultures of rat cortical neurons. Neurosci Lett. 212:1996;159-162.
18. Wood J.N. Regulation of NF-κB activity in rat dorsal root ganglia and PC12 cells by tumour necrosis factor and nerve growth factor. Neurosci Lett. 192:1995;41-44.
19. Grilli M., Goffi F., Memo M., Spano P.F. Interleukin-1β and glutamate activate the NF-κB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem. 271:1996;15002-15007.
20. Grilli M., Pizzi M., Memo M., Spano P.F. Neuroprotection by salicylate through blockade of NF-κB activation. Science. 274:1996;1383-1385.
21. Yan S.D., Yan S.F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M.A., Perry G., Godman G.C., Nawroth P., Zweier J.L., Stern D. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat Med. 1:1995;693-699.
22. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
23. Kaltschmidt B., Uherek M., Volk B., Baeuerle P.A., Kaltschmidt C. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA. 94:1997;2642-2647.
24. Wu H., Lozano G. NF-κB activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem. 269:1994;20067-20074.
25. Uberti D., Belloni M., Grilli M., Spano P.F., Memo M. Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. Eur J Neurosci. 10:1998;246-254.
26. Yang K., Mu X.S., Hayes R.L. Increased cortical nuclear factor-κB DNA binding activity after traumatic brain injury. Neurosci Lett. 197:1995;101-104.
27. Salminen A., Liu P.K., Hsu C.Y. Alteration of transcription factor binding activities in the ischemic rat brain. Biochem Biophys Res Commun. 212:1995;939-944.
28. Clemens J.A., Stephenson D.T., Smalstig E.B., Dixon E.P., Little S.P. Global ischemia activates nuclear factor-κB in forebrain neurons of rats. Stroke. 28:1997;1073-1080.
29. Prasad A.V., Pilcher W.H., Joseph S.A. Nuclear factor-κB in rat brain Enhanced DNA-binding activity following convulsant-induced seizures . Neurosci Lett. 170:1994;145-148.
30. Rong Y., Baudry M. Seizure activity results in a rapid induction of nuclear factor-κB in adult but not juvenile rat limbic structures. J Neurochem. 67:1996;662-668.
31. Terai K., Matsuo A., McGeer P.L. Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res. 735:1996;159-168.
32. Boissiere F., Hunot S., Faucheaux B., Duyckaerts C., Hauw J.J., Agid Y., Hirsch E.C. Nuclear translocation of NF-κB in cholinergic neurons of patients with Alzheimer's disease. Neuro report. 8:1997;2849-2852.
33. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.-P., Ruberg M., Faucheux B.A., Agid Y., Hirsch E.C. Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci USA. 94:1997;7531-7536.
34. Atwood W.J., Tornatore C.S., Traub R., Conant K., Drew P.D., Major E.O. Stimulation of HIV type 1 gene expression and induction of NF-κB (p50/p65)-binding activity in tumor necrosis factor α-treated human fetal glial cells. AIDS Res Hum Retroviruses. 10:1994;1207-1211.
35. Mayreddy R.P.R., Safak M., Razmara M., Zoltick P., Khalili K. Transcription of the JC virus archetype late genome Importance of the κB and the 23-base-pair motifs in late promoter activity in glial cells . J Virol. 70:1996;2387-2393.
36. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Patanjali S.R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G.J., Taylor A.M.R., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
37. Jung M., Zhang Y., Lee S., Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by truncated IκB-α Science. 268:1995;1619-1621.
38. Kuljis R.O., Xu Y., Aguila M.C., Baltimore D. Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc Natl Acad Sci USA. 94:1997;12688-12693.
39. McGeer P.L., McGeer E.G. The inflammatory response system of brain Implications for therapy of Alzheimer and other neurodegenerative diseases . Brain Res Brain Res Rev. 21:1995;195-218.
40. Grilli M., Memo M. Transcriptional pharmacology of neurodegenerative disorders Novel venue towards neuroprotection against excitotoxicity? Mol Psychiatry. 2:1997;192-194.
41. 2+ accumulation . Proc Natl Acad Sci USA. 92:1995;9328-9332.
42. Barger S.W., Mattson M.P. Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Brain Res Mol Brain Res. 40:1996;116-126.
43. Lipton S.A. Janus faces of NF-κB Neurodestruction versus neuroprotection . Nat Med. 3:1997;20-22.
44. Baichwal V.R., Baeuerle P.A. Apoptosis Activate NF-κB or die? Curr Biol. 7:1997;93-96.
45. Lehming N., Thanos D., Brickman J.M., Ma J., Maniatis T., Ptashne M. An HMG-like protein that can switch a transcriptional activator to a repressor. Nature. 371:1994;175-179.
46. Liu F.C., Graybiel A.M. Spatiotemporal dynamics of CREB phosphorylation Transient versus sustained phosphorylation in the developing striatum . Neuron. 17:1996;1133-1144.
47. Auphan N., DiDonato J.A., Caridad R., Helmberg A., Karin M. Immunosuppression by glucocorticoids Inhibition of NF-κB activity through induction of IκB synthesis . Science. 270:1995;286-290.
48. Scheinman R., Cogwell P., Lofquist A., Baldwin A. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286.
49. Ray A., Prefontaine K. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA. 91:1994;752-756.
50. Kopp E., Gosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 265:1994;956-958.
51. Ritchie D.M., Argentieri D.C., Aparicio B.L., Plante R.K., Lau C.Y., Barbone A.G. Cytokine-modulating activity of tepoxaline, a new potential antirheumatic. Int J Immunopharmacal. 17:1995;805-812.
52. Sappey C., Boelaert J.R., Legrand-Poels S., Forceille C., Favier A., Piette J. Iron chelation decreases NF-κB and HIV-1 activation due to oxidative stress. AIDS Res Hum Retroviruses. 11:1995;1049-1061.
53. Singh S., Aggarwal B.B. Activation of transcription factor NF-κB is suppressed by curcumin (diferulolylmethane). J Biol Chem. 270:1995;24995-25000.
54. Neisch A.S., Read M.A., Thanos D., Pine R., Maniatis T., Collins T. Endothelial interferon regulatory factor I cooperates with NF-κB as a transcriptional activator of vascular cell adhesion molecule. Mol Cell Biol. 15:1995;2558-2569.
55. Drew P.D., Franzoso G., Carlson L.M., Biddison W.E., Siebenlist U., Ozato K. Interferon regulatory factor-2 physically interacts with NF-κB in vitro and inhibits NF-κB induction of major histocompatibility class I and β2-microglobulin gene expression in transfected human neuroblastoma cells. J Neuroimmunol. 63:1995;157-162.
56. Lin Y.L., Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccaride-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol. 52:1997;465-472.
57. Meyer S., Kohler N.G., Joly A. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-κB activation. FEBS Lett. 413:1997;354-358.
58. Wang P., Wu P., Siegel M., Egan R., Billah M. Interleukin-10 inhibits nuclear NF-κB activation in human monocytes IL-10 and IL-4 suppress cytokine synthesis by different mechanisms . J Biol Chem. 270:1995;9558-9563.
59. Mahon T.M., O'Neill L.A.J. Studies into the effect of tyrosine kinase inhibitor herbimycin A on NF-κB activation in T lymphocytes. J Biol Chem. 270:1995;28557-28564.
60. Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T. Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res. 24:1996;2236-2242.